EPO and Hypertension: Sympathetic overactivity, the renin-angiotensin-aldosterone system (RAAS), endothelium-derived mediators, erythropoietin-stimulating agents, dialysis-specific factors, and arterial stiffness have also been hypothesized to play a role in intradialytic hypertension [26].